Organoidsciences Ltd. (KOSDAQ:476040)
South Korea · Delayed Price · Currency is KRW 11,920
+560 (4.93%)
At close: Jun 10, 2026
Organoidsciences Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -16,138 | -15,368 | -11,246 | -38,687 | -24,111 |
Depreciation & Amortization | 1,445 | 1,445 | 1,304 | 1,144 | 804.46 |
Loss (Gain) From Sale of Investments | -479.76 | -479.76 | -163.05 | -43.05 | - |
Stock-Based Compensation | 830.57 | 830.57 | 969.5 | 979.19 | 542.39 |
Other Operating Activities | 335.83 | -5.26 | 79.15 | 29,853 | 13,990 |
Change in Accounts Receivable | -25.39 | -25.39 | 149.39 | -393.5 | 0.78 |
Change in Inventory | - | - | 26.82 | -26.23 | - |
Change in Accounts Payable | 49.51 | 49.51 | 0.74 | 14.88 | - |
Change in Income Taxes | - | - | - | 0.74 | - |
Change in Other Net Operating Assets | -781.56 | -435.83 | -260.43 | -90.48 | 256.22 |
Operating Cash Flow | -14,764 | -13,989 | -9,141 | -7,248 | -8,518 |
Capital Expenditures | -3,689 | -1,923 | -667.07 | -947.83 | -1,787 |
Sale of Property, Plant & Equipment | 157.71 | - | - | 6.16 | - |
Sale (Purchase) of Intangibles | -61.36 | -41.35 | -120.21 | -70.5 | -16.88 |
Investment in Securities | -3,847 | -6,038 | 5,761 | 5,632 | -25,434 |
Other Investing Activities | 39.65 | -180.45 | -48.27 | -19.93 | -1,094 |
Investing Cash Flow | -9,034 | -8,182 | 4,925 | 4,600 | -28,332 |
Short-Term Debt Issued | - | - | 3,000 | - | 300 |
Long-Term Debt Issued | - | - | 700 | - | - |
Total Debt Issued | - | - | 3,700 | - | 300 |
Short-Term Debt Repaid | - | - | -300 | - | - |
Long-Term Debt Repaid | - | -473.78 | -217.49 | -218 | -231.04 |
Total Debt Repaid | -637.01 | -473.78 | -517.49 | -218 | -231.04 |
Net Debt Issued (Repaid) | -637.01 | -473.78 | 3,183 | -218 | 68.96 |
Issuance of Common Stock | 25,243 | 25,236 | 200 | 250 | - |
Other Financing Activities | 673.54 | 644.44 | 280.79 | 148.42 | 218.27 |
Financing Cash Flow | 25,279 | 25,407 | 3,663 | 180.43 | 11,286 |
Foreign Exchange Rate Adjustments | 141.07 | 56.98 | 44.82 | -74.93 | - |
Net Cash Flow | 1,622 | 3,292 | -507.22 | -2,543 | -25,563 |
Free Cash Flow | -18,453 | -15,912 | -9,808 | -8,196 | -10,304 |
Free Cash Flow Margin | -803.86% | -661.20% | -502.11% | -515.13% | -2351.33% |
Free Cash Flow Per Share | - | -2605.80 | -2346.73 | -2859.93 | -3595.68 |
Cash Interest Paid | 299.97 | 349.7 | 301.32 | 341.67 | 123.02 |
Cash Income Tax Paid | - | -37.03 | -34.04 | 114.09 | - |
Levered Free Cash Flow | - | -8,204 | -68,924 | 15,049 | - |
Unlevered Free Cash Flow | - | -7,977 | -66,930 | 18,794 | - |
Change in Working Capital | -757.44 | -411.72 | -83.47 | -494.59 | 257 |